| Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ... Cancer cell 32 (3), 295-309. e12, 2017 | 189 | 2017 |
| Modulation of target antigen density improves CAR T-cell functionality and persistence S Ramakrishna, SL Highfill, Z Walsh, SM Nguyen, H Lei, JF Shern, H Qin, ... Clinical Cancer Research 25 (17), 5329-5341, 2019 | 156 | 2019 |
| Demonstration That the Radical S-Adenosylmethionine (SAM) Enzyme PqqE Catalyzes de Novo Carbon-Carbon Cross-linking within a Peptide Substrate PqqA in the Presence of the … I Barr, JA Latham, AT Iavarone, T Chantarojsiri, JD Hwang, JP Klinman Journal of Biological Chemistry 291 (17), 8877-8884, 2016 | 123 | 2016 |
| GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ... Cancer Cell 40 (1), 53-69. e9, 2022 | 117 | 2022 |
| Tumor stroma–targeted antibody-drug conjugate triggers localized anticancer drug release C Szot, S Saha, XM Zhang, Z Zhu, MB Hilton, K Morris, S Seaman, ... The Journal of clinical investigation 128 (7), 2927-2943, 2018 | 102 | 2018 |
| Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction JS Tran, O Havakuk, JM McLeod, J Hwang, HY Kwong, D Shavelle, ... ESC Heart Failure 8 (2), 1706-1710, 2021 | 27 | 2021 |
| Acral lentiginous melanoma—population, treatment, and survival using the NCDB from 2004 to 2015 SX Bian, L Hwang, J Hwang, O Ragab, GK In, D Peng, E Lin Pigment cell & melanoma research 34 (6), 1049-1061, 2021 | 17 | 2021 |
| Delivery of formulated industrial enzymes with acoustic technology JD Hwang, M Ortiz-Maldonado, S Paramonov Journal of Laboratory Automation 21 (1), 153-165, 2016 | 2 | 2016 |
| Concordance of Next-Generation Sequencing and Multiparametric Flow Cytometry Methods for Detecting Measurable Residual Disease in Adult Acute Lymphoblastic Leukemia: Optimizing … K Ashouri, V Nittur, AA Ginosyan, J Hwang, B Adnani, D Chen, ... Clinical Lymphoma Myeloma and Leukemia 24 (3), e59-e66. e2, 2024 | 1 | 2024 |
| Blinatumomab Therapy for Low Level Minimal Residual Disease Detected By Next-Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia K Ashouri, B Hom, J Hwang, K Resnick, AA Ginosyan, A Ali, G Yaghmour Blood 142, 6058, 2023 | 1 | 2023 |
| The antibody-drug conjugate D3-GPC2-PBD potently eradicates neuroblastoma patient-derived xenografts KR Bosse, Z Zhu, M Lane, D Martinez, J DeLong, DV Zhelev, Y Feng, ... Cancer Research 78 (13_Supplement), 4636-4636, 2018 | 1 | 2018 |
| Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a … K Ashouri, AA Ginosyan, M Chu, B Hom, J Hwang, K Resnick, Y Rahimi, ... Leukemia Research 141, 107501, 2024 | | 2024 |
| B-Cell Acute Lymphoblastic Leukemia: Donor Matters in Allogeneic Stem Cell Transplant Outcomes of Hispanic Patients M Chu, K Ashouri, BM Hom, J Hwang, K Resnick, Y Rahimi, R Ireland, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| B-Cell Acute Lymphoblastic Leukemia: Donor Matters in Allogeneic Stem Cell Transplant Outcomes of Hispanic Patients K Ashouri, B Hom, M Chu, J Hwang, K Resnick, Y Rahimi, R Ireland, ... Blood 142, 2241, 2023 | | 2023 |
| Philadelphia-like B-Cell Acute Lymphoblastic Leukemia in a Largely Hispanic Population: Disease Features and Outcomes in the Era of Immunotherapy a Single Institutional Study K Ashouri, B Hom, Y Rahimi, K Resnick, V Nittur, J Hwang, B Adnani, ... Blood 142, 4208, 2023 | | 2023 |
| Potent activity of CAR T cells targeting the oncofetal protein GPC2 engineered to recognize low antigen density in neuroblastoma S Heitzeneder, KR Bosse, Z Zhu, D Jelev, S Dhingra, R Majzner, ... Cancer Research 81 (13_Supplement), 1548-1548, 2021 | | 2021 |
